| ID Source | ID |
|---|---|
| PubMed CID | 1036292 |
| CHEMBL ID | 1342288 |
| CHEBI ID | 114633 |
| Synonym |
|---|
| smr000121348 |
| 5-ethyl-2-(3,4,5-trimethoxy-benzoylamino)-thiophene-3-carboxylic acid ethyl ester |
| MLS000528873 |
| OPREA1_063583 |
| CHEBI:114633 |
| AKOS000676143 |
| ethyl 5-ethyl-2-[(3,4,5-trimethoxybenzoyl)amino]thiophene-3-carboxylate |
| STK744913 |
| ethyl 5-ethyl-2-{[(3,4,5-trimethoxyphenyl)carbonyl]amino}thiophene-3-carboxylate |
| HMS2333H19 |
| AB00096823-01 |
| CHEMBL1342288 |
| Q27196037 |
| 5-ethyl-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester |
| ethyl 5-ethyl-2-(3,4,5-trimethoxybenzamido)thiophene-3-carboxylate |
| SR-01000414908-1 |
| sr-01000414908 |
| Class | Description |
|---|---|
| benzamides | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 0.7079 | 0.0447 | 17.8581 | 100.0000 | AID485294 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 89.1251 | 0.6310 | 35.7641 | 100.0000 | AID504339 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 25.1189 | 0.0020 | 14.6779 | 39.8107 | AID1476 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 34.4117 | 0.1000 | 20.8793 | 79.4328 | AID588453; AID588456 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 29.0929 | 0.0041 | 10.8903 | 31.5287 | AID504467 |
| TDP1 protein | Homo sapiens (human) | Potency | 26.6321 | 0.0008 | 11.3822 | 44.6684 | AID686978; AID686979 |
| Smad3 | Homo sapiens (human) | Potency | 12.5893 | 0.0052 | 7.8098 | 29.0929 | AID588855 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 1.9953 | 0.7079 | 12.1943 | 39.8107 | AID720542 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 35.4813 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 14.1254 | 0.0355 | 20.9770 | 89.1251 | AID504332 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 35.4813 | 0.0018 | 15.6638 | 39.8107 | AID894 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 79.4328 | 0.0060 | 26.1688 | 89.1251 | AID540317 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 22.3872 | 0.0041 | 9.9848 | 25.9290 | AID504444 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 39.8107 | 0.0041 | 9.9625 | 28.1838 | AID2675 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 1.9953 | 1.0000 | 10.4756 | 28.1838 | AID1457 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | Active Concentration | 20.0000 | 20.0000 | 20.0000 | 20.0000 | AID1421 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| 3-aminobenzamide | [no description available] | low | 0 | 0 | benzamides; substituted aniline | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
| dan 2163 | [no description available] | low | 0 | 0 | aromatic amide; aromatic amine; benzamides; pyrrolidines; sulfone | environmental contaminant; second generation antipsychotic; xenobiotic |
| benzamide | [no description available] | low | 0 | 0 | benzamides | |
| bromopride | [no description available] | low | 0 | 0 | benzamides | |
| ci 994 | [no description available] | low | 0 | 0 | acetamides; benzamides; substituted aniline | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor |
| cisapride | [no description available] | low | 0 | 0 | benzamides | |
| 2-hexyloxybenzamide | [no description available] | low | 0 | 0 | aromatic ether; benzamides | antifungal agent |
| itopride | [no description available] | low | 0 | 0 | benzamides | |
| labetalol | [no description available] | low | 0 | 0 | benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound | |
| lorglumide | [no description available] | low | 0 | 0 | benzamides; dicarboxylic acid monoamide; dichlorobenzene; glutamic acid derivative | |
| 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide | [no description available] | low | 0 | 0 | benzamides; hydroxamic acid; secondary carboxamide; tertiary amino compound | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
| metoclopramide | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; substituted aniline; tertiary amino compound | antiemetic; dopaminergic antagonist; environmental contaminant; gastrointestinal drug; xenobiotic |
| moclobemide | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; morpholines | antidepressant; environmental contaminant; xenobiotic |
| entinostat | [no description available] | low | 0 | 0 | benzamides; carbamate ester; primary amino compound; pyridines; substituted aniline | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
| deet | [no description available] | low | 0 | 0 | benzamides; monocarboxylic acid amide | environmental contaminant; insect repellent; xenobiotic |
| acecainide | [no description available] | low | 0 | 0 | acetamides; benzamides | anti-arrhythmia drug |
| nemonapride | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; monomethoxybenzene; N-alkylpyrrolidine; secondary amino compound; secondary carboxamide; substituted aniline | |
| niclosamide | [no description available] | low | 0 | 0 | benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide | anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor |
| picotamide | [no description available] | low | 0 | 0 | benzamides | |
| procainamide | [no description available] | low | 0 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
| procarbazine | [no description available] | low | 0 | 0 | benzamides; hydrazines | antineoplastic agent |
| proglumetacin | [no description available] | low | 0 | 0 | aromatic ether; benzamides; carboxylic ester; monochlorobenzenes; N-acylindole; N-alkylpiperazine | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug |
| proglumide | [no description available] | low | 0 | 0 | benzamides; dicarboxylic acid monoamide; glutamine derivative; racemate | anti-ulcer drug; cholecystokinin antagonist; cholinergic antagonist; delta-opioid receptor agonist; drug metabolite; gastrointestinal drug; opioid analgesic; xenobiotic metabolite |
| imatinib | [no description available] | low | 0 | 0 | aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines | antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor |
| sulpiride | [no description available] | low | 0 | 0 | benzamides; N-alkylpyrrolidine; sulfonamide | antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist |
| tiapride | [no description available] | low | 0 | 0 | benzamides | |
| trimethobenzamide | [no description available] | low | 0 | 0 | benzamides; tertiary amino compound | antiemetic |
| troxipide | [no description available] | low | 0 | 0 | benzamides | |
| zm 336372 | [no description available] | low | 0 | 0 | benzamides | |
| iodohippuric acid | [no description available] | low | 0 | 0 | benzamides; N-acylglycine; organoiodine compound | |
| benzoylarginine-2-naphthylamide | [no description available] | low | 0 | 0 | arginine derivative; benzamides; N-(2-naphthyl)carboxamide | |
| 4-(benzoylamino)-2-hydroxybenzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| ameltolide | [no description available] | low | 0 | 0 | benzamides | |
| antimycin a | [no description available] | low | 0 | 0 | benzamides; formamides; macrodiolide; phenols | antifungal agent; mitochondrial respiratory-chain inhibitor; piscicide |
| rebemide | [no description available] | low | 0 | 0 | benzamides | |
| 2,6-dichlorobenzamide | [no description available] | low | 0 | 0 | benzamides; dichlorobenzene | herbicide; marine xenobiotic metabolite |
| fluorophene | [no description available] | low | 0 | 0 | benzamides | |
| 2-toluanilide | [no description available] | low | 0 | 0 | benzamides; benzanilide fungicide | |
| 2-bromo-N-phenylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| xipamide | [no description available] | low | 0 | 0 | benzamides | |
| capobenic acid | [no description available] | low | 0 | 0 | benzamides | |
| pronamide | [no description available] | low | 0 | 0 | benzamides; dichlorobenzene; terminal acetylenic compound | agrochemical; herbicide |
| clanobutin | [no description available] | low | 0 | 0 | benzamides | |
| nitazoxanide | [no description available] | low | 0 | 0 | benzamides; carboxylic ester | |
| Flamprop | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(dimethylamino)phenyl]-3,4,5-trimethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| endralazine | [no description available] | low | 0 | 0 | benzamides | |
| flutolanil | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; benzamides; benzanilide fungicide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
| encainide | [no description available] | low | 0 | 0 | benzamides; piperidines | anti-arrhythmia drug; sodium channel blocker |
| nelfinavir | [no description available] | low | 0 | 0 | aryl sulfide; benzamides; organic heterobicyclic compound; phenols; secondary alcohol; tertiary amino compound | antineoplastic agent; HIV protease inhibitor |
| n-benzoylpiperidine | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| pancopride | [no description available] | low | 0 | 0 | benzamides | |
| octylonium | [no description available] | low | 0 | 0 | benzamides | |
| parsalmide | [no description available] | low | 0 | 0 | benzamides | |
| isoxaben | [no description available] | low | 0 | 0 | benzamides; isoxazoles | cellulose synthesis inhibitor; herbicide |
| 4-aminobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-Methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| benzoyltyrosine ethyl ester | [no description available] | low | 0 | 0 | benzamides; ethyl ester; L-tyrosine derivative; phenols | chromogenic compound |
| salifungin | [no description available] | low | 0 | 0 | benzamides | |
| n-benzoyl-l-arginine | [no description available] | low | 0 | 0 | benzamides; N-acyl-L-arginine | |
| gr 127935 | [no description available] | low | 0 | 0 | 1,2,4-oxadiazole; benzamides; N-alkylpiperazine; N-arylpiperazine | |
| zacopride | [no description available] | low | 0 | 0 | benzamides | |
| mozavaptan | [no description available] | low | 0 | 0 | benzamides | aquaretic |
| mosapride | [no description available] | low | 0 | 0 | aromatic ether; benzamides; monochlorobenzenes; monofluorobenzenes; morpholines; secondary carboxamide; substituted aniline; tertiary amino compound | |
| zoxamide | [no description available] | low | 0 | 0 | alpha-chloroketone; benzamides; dichlorobenzene | |
| procainamide 4-hydroxylamine | [no description available] | low | 0 | 0 | benzamides; hydroxylamines | drug metabolite |
| ly 188544 | [no description available] | low | 0 | 0 | benzamides | |
| gr 55562 | [no description available] | low | 0 | 0 | benzamides | |
| n-(2,6-dimethylphenyl)-4-(((diethylamino)acetyl)amino)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| tariquidar | [no description available] | low | 0 | 0 | benzamides | |
| n-benzoyltyrosine | [no description available] | low | 0 | 0 | benzamides; N-acyl-L-tyrosine | |
| rp 73401 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; chloropyridine; monocarboxylic acid amide | anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; phosphodiesterase IV inhibitor |
| brovanexine | [no description available] | low | 0 | 0 | benzamides | |
| aminopotentidine | [no description available] | low | 0 | 0 | aromatic ether; benzamides; guanidines; nitrile; piperidines; substituted aniline | H2-receptor antagonist |
| asperphenamate | [no description available] | low | 0 | 0 | benzamides; carboxylic ester; L-phenylalanine derivative | antineoplastic agent |
| N-(3-fluorophenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| benzoylphenylalanine | [no description available] | low | 0 | 0 | benzamides; N-acyl-amino acid | |
| 2-methoxy-N-[2-(methylthio)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-fluorobenzoylamino)benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| xv 638 | [no description available] | low | 0 | 0 | 1,3-thiazoles; benzamides; diazepanone; diol; secondary alcohol; secondary carboxamide; ureas | HIV protease inhibitor |
| roflumilast | [no description available] | low | 0 | 0 | aromatic ether; benzamides; chloropyridine; cyclopropanes; organofluorine compound | anti-asthmatic drug; phosphodiesterase IV inhibitor |
| 2-(3-benzamidophenoxy)acetic acid | [no description available] | low | 0 | 0 | benzamides | |
| ck-0944666 | [no description available] | low | 0 | 0 | benzamides; indoles; organofluorine compound | actin polymerisation inhibitor |
| gw9662 | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-N-[6-(1-oxobutylamino)-3-pyridinyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-2-[(2,4-dimethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| [3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-phenylmethanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 4-methyl-N-[2-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-(2-ethyl-5-tetrazolyl)phenyl]-3-(1-tetrazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-(2-ethyl-5-tetrazolyl)phenyl]-4-(1-tetrazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2,5-diethoxy-4-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| (2,4-difluorophenyl)-[3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-(2-methyl-5-tetrazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2,5-dimethoxy-4-[[2-(4-morpholinyl)-1-oxoethyl]amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-fluorophenyl)-4-(2-oxolanylmethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| azidopine | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N1,N3-bis(3-pyridinyl)benzene-1,3-dicarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 2,3,4,5,6-pentafluoro-N-(phenylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(1,1-dioxo-3-thiolanyl)-N-(thiophen-2-ylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-methoxyphenyl)-2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(4-acetyloxy-3-methoxyphenyl)-oxomethyl]amino]-5-hydroxybenzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetamidophenyl)-4-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetamidophenyl)-3-chlorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-tert-butyl-N-[4-(4-morpholinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-fluorophenyl)-4-phenylmethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[4-(4-morpholinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-(3-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-N-(2-pyridinyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-(4-oxo-3,1-benzoxazin-2-yl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[(4-pyrimidinylthio)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-acetamidophenyl)-2-bromobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-acetyl-4-methyl-2-thiazolyl)-4-tert-butylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-acetyl-4-methyl-2-thiazolyl)-2-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,4-dimethoxyphenyl)-4-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-[(4-methylanilino)-oxomethyl]phenyl]-3-pyridinecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(2,5-dimethyl-1-pyrrolyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-3-(trifluoromethyl)phenyl]-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetamidophenyl)-2-chlorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-ethoxy-N-(2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-(3-methoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2,4-difluorophenyl)-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(4-acetyloxy-3-methoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| acetic acid [4-[(4-hydroxyanilino)-oxomethyl]-2-methoxyphenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-benzamido-2-chlorophenyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(hydroxymethyl)-N-(phenylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(3-methylphenyl)-oxomethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-chloro-4-methyl-N-[4-(4-methyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-ethoxy-N-(2-hydroxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[(3-chloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-N-(4-methylphenyl)-4-(methylthio)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[(4-methoxyphenyl)-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-3-methyl-N-[4-(4-morpholinylmethyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-anilinophenyl)-3,4-dimethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[[(6-methyl-4-pyrimidinyl)thio]methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetamidophenyl)-2-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-acetylphenyl)-3-ethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(3-bromophenyl)-oxomethyl]amino]-5-hydroxybenzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-N-[4-(2-imidazo[1,2-a]pyridinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[[3-(4-methoxyphenyl)phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 3-[(4-ethoxyphenoxy)methyl]-N,N-diethylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-tert-butyl-N-(4-methyl-3-nitrophenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-methoxyphenyl)-4-[(2-methyl-1-oxopropyl)amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3,4,5-trimethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-methoxyphenyl)-2-(methylthio)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]phenyl]carbamic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2,4-dimethyl-N-[4-(1-pyrrolidinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(7-bromo-3,4-dihydro-2H-1,5-benzodioxepin-8-yl)-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 5-chloro-N-(2-furanylmethyl)-2-[[(4-methoxyphenyl)-oxomethyl]amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[(2-bromophenoxy)methyl]-N-[4-[(3,5-dimethyl-1-pyrazolyl)methyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-bromo-5-ethoxy-N-(4-fluorophenyl)-4-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 4-[4-[[(3,4-dimethylphenyl)-oxomethyl]amino]phenoxy]phthalic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-2-[(2-ethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[[3-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 3,4-dimethoxy-N-[4-[oxo(1-piperidinyl)methyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-fluoro-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-benzamido-3-methylphenyl)-1,3-benzodioxole-5-carboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-benzamidophenyl)-1,3-benzodioxole-5-carboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2,2-dichloro-1-(4-chlorophenyl)sulfonylethenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[3-[2-(4-methylphenyl)sulfonylethylthio]phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-N-[3-chloro-4-(4-morpholinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-methoxyphenyl)-4-(1-oxopropylamino)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| [2-methoxy-4-(methylthio)phenyl]-[4-(phenylmethyl)-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| N-[2,5-diethoxy-4-[[(3-methoxyanilino)-sulfanylidenemethyl]amino]phenyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]-4-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-chloro-3-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-(3-chlorophenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-chloro-2-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 3-(1,3-dioxo-2-isoindolyl)propanoic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 5-bromo-2-furancarboxylic acid (3-benzamidophenyl) ester | [no description available] | low | 0 | 0 | benzamides | |
| (4-ethoxyphenyl)-[4-[(4-ethoxyphenyl)-oxomethyl]-1,4-diazepan-1-yl]methanone | [no description available] | low | 0 | 0 | benzamides | |
| [4-[(2-bromophenoxy)methyl]phenyl]-(1-piperidinyl)methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 3-[(4-bromophenoxy)methyl]-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-methyl-N-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[methyl(phenyl)sulfamoyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[(N-methylanilino)-oxomethyl]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-[2-nitro-4-(trifluoromethyl)phenoxy]-N-phenylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[(4-methoxyphenyl)-oxomethyl]amino]methyl]-5-phenyl-3-furancarboxylic acid | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,5-dichlorophenyl)-2-(methanesulfonamido)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-chloro-2-methylphenyl)-4-[(4-chloro-1-pyrazolyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[2-[(4-chlorophenyl)thio]-1-oxoethyl]amino]-N-(4-methoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[2-(4-morpholinyl)phenyl]-3-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-[4-(4-methyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[[[(5-bromo-2-furanyl)-oxomethyl]hydrazo]-oxomethyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 5-bromo-2-methoxy-3-methyl-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-4,5-dimethoxybenzoic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2,4,5-trimethoxy-N-(2-phenylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-ethoxy-N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[3-methyl-4-[[2-(3-nitrophenoxy)-1-oxoethyl]amino]phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[2-methyl-1,3-bis[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]propan-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| [4-[(2,4-dichlorophenoxy)methyl]phenyl]-(4-methyl-1-piperazinyl)methanone | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-furanylmethyl)-2-[[[2-[(4-methylphenyl)sulfonyl-(phenylmethyl)amino]phenyl]-oxomethyl]amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(2-cyanophenyl)thio]-N-[4-[dimethylamino(oxo)methyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-furanylmethyl)-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[(3-benzamidoanilino)-sulfanylidenemethyl]-2-thiophenecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-cyano-N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-tert-butyl-N-[2,5-dimethoxy-4-[[1-oxo-2-(1-piperidinyl)ethyl]amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| (2,6-difluorophenyl)-[4-(5-fluoro-2-methyl-1-benzimidazolyl)-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| (4-chlorophenyl)-[4-[[(2,4-dichlorophenyl)thio]methyl]-4-hydroxy-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| N-(4-bromo-2,6-dimethylphenyl)-2-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(3,6-dichloro-2-methoxyphenyl)-oxomethyl]amino]benzoic acid propyl ester | [no description available] | low | 0 | 0 | benzamides | |
| N-(2,4-dichlorophenyl)-4-phenylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-butoxy-N-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| fm19g11 | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[(4,6-dimethyl-2-pyrimidinyl)sulfamoyl]phenyl]-2-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[(3-methyl-1-oxobutyl)amino]-sulfanylidenemethyl]amino]-N-phenylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(4-tert-butylphenyl)-oxomethyl]amino]-3-methyl-2-sulfanylidene-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 3-methoxy-N-(2,3,4-trifluorophenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-phenylacetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(2-nitrophenyl)-oxomethyl]amino]benzoic acid propyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[oxo-(2,3,4,5,6-pentafluorophenyl)methyl]amino]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-[3-(1-oxopentylamino)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[(2,4-dichlorophenoxy)methyl]-N-[2-(dimethylamino)ethyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-methoxy-N-[2-(3-methoxyphenoxy)ethyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,5-dimethyl-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[[3-[(3-nitrophenyl)sulfamoyl]phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-3-[(2,5-dimethylphenyl)sulfamoyl]-N-(2-phenylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-(2-phenylphenyl)-3-(phenylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 3,4-dimethoxy-N-[4-(2,2,3,3-tetrafluoropropoxy)-3-(trifluoromethyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 1-azepanyl-[2-[4-(difluoromethylthio)anilino]phenyl]methanone | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[(4-tert-butylphenyl)-oxomethyl]amino]-1H-1,2,4-triazole-5-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-bromo-N-(4-ethylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-amino-N-(2-methoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-(difluoromethoxy)-N-[5-[[4-(difluoromethylthio)phenyl]methyl]-2-thiazolyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(4-ethoxyphenyl)sulfonylamino]-N-[2-(4-morpholinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-(dimethylamino)-N-[2-(1,2,4-triazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(2,5-dimethylphenyl)sulfonylamino]-N-[4-(2-pyrimidinylsulfamoyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-methoxy-5-methylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[1-methyl-2-oxo-6-(trifluoromethyl)-3-pyridinyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[1-methyl-2-oxo-6-(trifluoromethyl)-3-pyridinyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[2-(4-fluoroanilino)-2-oxoethoxy]-3-methoxy-N-[4-(4-methoxyphenyl)-5-methyl-2-thiazolyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[3-[2-(2-carbamoylphenoxy)-1-oxoethyl]-2,5-dimethyl-1-pyrrolyl]propanoic acid methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 5-(dimethylsulfamoyl)-N-(diphenylmethyl)-2-(1-pyrrolidinyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[(3-fluoro-4-methoxyphenyl)methoxy]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-chloro-2-methoxy-5-methylphenyl)-4-[(3,4-difluorophenyl)sulfonylamino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[(3-methylphenyl)-oxomethyl]amino]benzoic acid (3,5-dimethyl-4-isoxazolyl)methyl ester | [no description available] | low | 0 | 0 | benzamides | |
| 4-(dimethylsulfamoyl)-N-(3-methylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-chloro-2-(4-methyl-1-piperazinyl)phenyl]-3-(dimethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-methoxy-N-(4-methyl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-(diethylsulfamoyl)-N-(3,5-dimethylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,4-dimethyl-N-[4-(4-methylpiperazino)benzyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(5-oxazolyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N1-(2,6-dimorpholino-3-pyridyl)-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-3,4-dimethylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| sirtinol | [no description available] | low | 0 | 0 | aldimine; benzamides; naphthols | anti-inflammatory agent; EC 3.5.1.98 (histone deacetylase) inhibitor; Sir2 inhibitor |
| N-[1-(3-methoxyphenyl)-3-(1-naphthalenylamino)-3-oxopropyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-(1-naphthalenylamino)-3-oxo-1-phenylpropyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-chloro-3-(diethylsulfamoyl)-N-(2-nitrophenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-methoxy-2-nitrophenyl)-3-[(2-methyl-1-oxopropyl)amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3,4,5-triethoxy-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[[4-[[2-(4-chloro-2-methylphenoxy)-1-oxopropyl]amino]phenyl]-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-chloro-2-hydroxyphenyl)-2-ethoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-[(2-furanylmethylamino)-oxomethyl]phenyl]-4-methyl-3-(1-piperidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[4-[1-[(4-methoxyanilino)-oxomethyl]cyclopentyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-chloro-2-(1-piperidinyl)phenyl]-4-(4-morpholinyl)-3-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(6-imidazo[2,1-b]thiazolyl)phenyl]-4-methoxy-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| norcisapride | [no description available] | low | 0 | 0 | benzamides | |
| prucalopride | [no description available] | low | 0 | 0 | benzamides | |
| Dihydroalatamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methoxy-N-[2,2,2-trichloro-1-(4-methylanilino)ethyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-hydroxy-5-nitrophenyl)-3-nitrobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-(1,3-benzothiazol-2-ylthio)-5-nitrophenyl]-2-fluorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-[5-[(4-tert-butylphenyl)methylthio]-1,3,4-oxadiazol-2-yl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-butan-2-yl-4-[4-oxo-3-(phenylmethyl)-2-thiazolidinyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[3-(2-furanylmethyl)-4-oxo-2-thiazolidinyl]-N-(3-propan-2-yloxypropyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-methyl-N-[1-(4-prop-2-enyl-5-sulfanylidene-1H-1,2,4-triazol-3-yl)ethyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(2-oxolanylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-[[(3-methoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[oxo-[3-(1-piperidinylsulfonyl)phenyl]methyl]amino]benzoic acid | [no description available] | low | 0 | 0 | benzamides | |
| N-(4-ethoxyphenyl)-2-(hydroxymethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(5-acetyl-2-phenyl-4-sulfanylidene-1H-pyrimidin-6-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| sb-224289 | [no description available] | low | 0 | 0 | 1,2,4-oxadiazole; azaspiro compound; benzamides; organic heterotetracyclic compound | serotonergic antagonist |
| N-[(4-methylphenyl)methyl]-4-(1-pyrrolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 1-[(4-chlorophenyl)-oxomethyl]-N-[4-(1-piperidinylsulfonyl)phenyl]-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| N-(4-bromophenyl)-2-[(5,6-dimethyl-4-thieno[2,3-d]pyrimidinyl)thio]benzamide | [no description available] | low | 0 | 0 | benzamides; thienopyrimidine | |
| 4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-ethyl-3-[(4-fluorophenyl)-(4-morpholinyl)methyl]-2-thiophenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-cycloheptyl-4-(2-oxolanylmethoxy)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-methoxyphenyl)acetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| 2-methyl-3-nitro-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[4-[[(3-chlorophenyl)-oxomethyl]amino]phenyl]propanedioic acid dimethyl ester | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,5-dimethylphenyl)-2-(2-nitroethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-[[(4-tert-butylphenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-[(4-ethoxyphenyl)-[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-4,5-dimethyl-2-thiophenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-methoxy-N-(5-phenyl-1,2,4-thiadiazol-3-yl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-acetamido-N-[(4-ethoxy-3-methoxyphenyl)methyl]-4-[(4-methylphenyl)thio]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxo-1-pyrrolidinyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N,N-dimethylsulfamic acid [3-[(4-methoxyanilino)-oxomethyl]phenyl] ester | [no description available] | low | 0 | 0 | benzamides | |
| N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-3-[(4-chlorophenyl)sulfamoyl]phenyl]-4-propan-2-yloxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide | [no description available] | low | 0 | 0 | benzamides; benzodioxoles; imidazoles; pyridines | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| N-[3-[(2-bromo-5-methylphenyl)sulfamoyl]-4-methoxyphenyl]-4-fluorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]-4-[(3,5-dimethyl-4-isoxazolyl)methoxy]-3-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-cyano-N-[4-thiophen-2-yl-5-(2,2,2-trifluoro-1-oxoethyl)-2-thiazolyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-(1-azepanylsulfonyl)-N-[5-[(4-chlorophenyl)sulfamoyl]-2-hydroxyphenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-(4-fluorophenyl)-2-thiazolyl]-3-methoxy-4-[2-(4-morpholinyl)-2-oxoethoxy]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxolanylmethoxy)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-[(4-chlorophenyl)methylthio]-1H-1,2,4-triazol-5-yl]-4-cyanobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-(4-methylphenoxy)-N-[2-[oxo(1-piperidinyl)methyl]phenyl]acetamide | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| imd 0354 | [no description available] | low | 0 | 0 | benzamides | |
| N-(3-chlorophenyl)-3-[ethyl(phenyl)sulfamoyl]-4-fluorobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-tert-butyl-N-[3-[4-[3-[[(4-tert-butylphenyl)-oxomethyl]amino]propyl]-1-piperazinyl]propyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-amino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| tiapridex | [no description available] | low | 0 | 0 | benzamides | |
| [2-methoxy-5-[[4-(4-methylphenyl)-1-phthalazinyl]amino]phenyl]-(1-piperidinyl)methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| axitinib | [no description available] | low | 0 | 0 | aryl sulfide; benzamides; indazoles; pyridines | antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist |
| 4-[(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]-N-(3-ethylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| LSM-32377 | [no description available] | low | 0 | 0 | benzamides | |
| ispinesib | [no description available] | low | 0 | 0 | benzamides | |
| fk 866 | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| 4-acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| [4-[[4-(1-benzothiophen-2-yl)-2-pyrimidinyl]amino]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| midostaurin | [no description available] | low | 0 | 0 | benzamides; gamma-lactam; indolocarbazole; organic heterooctacyclic compound | antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor |
| bms201038 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; benzamides; fluorenes; piperidines | anticholesteremic drug; MTP inhibitor |
| mocetinostat | [no description available] | low | 0 | 0 | aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline | antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent |
| cgp 74588 | [no description available] | low | 0 | 0 | benzamides | |
| zm 447439 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; morpholines; polyether; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; Aurora kinase inhibitor |
| tak-715 | [no description available] | low | 0 | 0 | benzamides | |
| masitinib | [no description available] | low | 0 | 0 | 1,3-thiazoles; benzamides; N-alkylpiperazine; pyridines | antineoplastic agent; antirheumatic drug; tyrosine kinase inhibitor |
| N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide | [no description available] | low | 0 | 0 | 1,3,4-oxadiazoles; benzamides; biphenyls; nitrile | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| betrixaban | [no description available] | low | 0 | 0 | benzamides; guanidines; monochloropyridine; monomethoxybenzene; secondary carboxamide | anticoagulant; EC 3.4.21.6 (coagulation factor Xa) inhibitor |
| nigerloxin | [no description available] | low | 0 | 0 | aromatic ether; benzamides; benzoic acids; phenols; styrenes | antioxidant; Aspergillus metabolite; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; radical scavenger |
| myxochelin b | [no description available] | low | 0 | 0 | benzamides; catechols | bacterial metabolite; siderophore |
| fluopicolide | [no description available] | low | 0 | 0 | benzamide fungicide; benzamides; dichlorobenzene; monochloropyridine; organofluorine compound | antifungal agrochemical |
| eluxadoline | [no description available] | low | 0 | 0 | amino acid amide; benzamides; imidazoles; L-phenylalanine derivative; methoxybenzoic acid | delta-opioid receptor antagonist; gastrointestinal drug; kappa-opioid receptor agonist; mu-opioid receptor agonist |
| N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3,3-dimethylbutan-2-ylamino)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| chir 090 | [no description available] | low | 0 | 0 | acetylenic compound; benzamides; hydroxamic acid; L-threonine derivative; morpholines | antimicrobial agent; EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor; lipopolysaccharide biosynthesis inhibitor |
| ki11502 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; quinolines; thioureas | antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| az-628 | [no description available] | low | 0 | 0 | benzamides | |
| at 13387 | [no description available] | low | 0 | 0 | benzamides; isoindoles; N-alkylpiperazine; resorcinols; tertiary carboxamide | antineoplastic agent; Hsp90 inhibitor |
| 4-[[[2-(cyclohexylamino)-3,4-dioxo-1-cyclobutenyl]amino]methyl]-N-(4-ethoxyphenyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| chidamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(3,5-dichlorophenyl)-4-[(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| mdv 3100 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; benzamides; imidazolidinone; monofluorobenzenes; nitrile; thiocarbonyl compound | androgen antagonist; antineoplastic agent |
| 3-nitro-4-(2-oxolanylmethylamino)-N-(2-phenylethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-({2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}amino)benzamide | [no description available] | low | 0 | 0 | aminopyrimidine; benzamides | protein kinase inhibitor |
| azd 7545 | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; organofluorine compound; secondary carboxamide; sulfone; tertiary alcohol; tertiary carboxamide | EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor; hypoglycemic agent |
| N-[3-[2-(4-chloroanilino)-4-thiazolyl]phenyl]-3-(trifluoromethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-(trifluoromethyl)-N-[4-[2-[3-(trifluoromethyl)anilino]-4-thiazolyl]phenyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-5-oxazolecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-4-thiazolecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-(4-bromophenyl)-N-[5-[[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-oxomethyl]-2-methylphenyl]-1H-pyrazole-5-carboxamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[3-amino-1-[4-[2-(4-methoxyphenyl)ethylamino]-3-nitrophenyl]-3-oxopropyl]-4-bromobenzamide | [no description available] | low | 0 | 0 | benzamides | |
| nvp-bhg712 | [no description available] | low | 0 | 0 | benzamides | |
| respirantin | [no description available] | low | 0 | 0 | benzamides; cyclodepsipeptide; formamides; phenols | antimicrobial agent; antineoplastic agent; metabolite |
| N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3-methylbutan-2-ylamino)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| ph 797804 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; organobromine compound; organofluorine compound; pyridone | anti-inflammatory agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| 2-[(6-chloro-3-pyridinyl)sulfonylamino]-N-[(4-methylphenyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| lde225 | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; benzamides; biphenyls; morpholines; organofluorine compound; tertiary amino compound | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist |
| gdc 0449 | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; pyridines; sulfone | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist; teratogenic agent |
| 3-[[1-[1-(methylthio)propan-2-yl]-4-piperidinyl]oxy]-N-(2-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 3-[[1-(dimethylsulfamoyl)-4-piperidinyl]oxy]-N-[(3-methyl-5-isoxazolyl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| ponatinib | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; acetylenic compound; benzamides; imidazopyridazine; N-methylpiperazine | antineoplastic agent; tyrosine kinase inhibitor |
| N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide | [no description available] | low | 0 | 0 | benzamides; biphenyls; cyclopropanes; dicarboxylic acid diamide | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
| 4-tert-butyl-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| 4-ethoxy-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| GRL-0617 | [no description available] | low | 0 | 0 | benzamides; naphthalenes; secondary carboxamide; substituted aniline | anticoronaviral agent; protease inhibitor |
| n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide | [no description available] | low | 0 | 0 | aminopyrimidine; benzamides; morpholines; nitrile; secondary amino compound; tertiary amino compound | anti-anaemic agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
| N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonyl-1-piperazinyl)-1-piperidinyl]anilino]-4-pyrimidinyl]-2-imidazo[1,2-a]pyridinyl]-2-methoxybenzamide | [no description available] | low | 0 | 0 | benzamides | |
| entrectinib | [no description available] | low | 0 | 0 | benzamides; difluorobenzene; indazoles; N-methylpiperazine; oxanes; secondary amino compound; secondary carboxamide | antibacterial agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| ixazomib | [no description available] | low | 0 | 0 | benzamides; boronic acids; dichlorobenzene; glycine derivative | antineoplastic agent; apoptosis inducer; drug metabolite; orphan drug; proteasome inhibitor |
| N-(2-chlorophenyl)-4-[[2-[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]anilino]-5-fluoro-4-pyrimidinyl]amino]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-(2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | benzamides | |
| N-(2-aminophenyl)-4-[[[(2S,3S)-10-[[cyclohexyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzamide | [no description available] | low | 0 | 0 | benzamides | |
| KOM70144 | [no description available] | low | 0 | 0 | acetamides; benzamides; naphthalenes; secondary carboxamide | anticoronaviral agent; protease inhibitor |
| iwr-1 endo | [no description available] | low | 0 | 0 | benzamides; bridged compound; dicarboximide; quinolines | axin stabilizer; Wnt signalling inhibitor |
| ulixacaltamide | [no description available] | low | 0 | 0 | benzamides; monochlorobenzenes; monofluorobenzenes; piperidines; secondary carboxamide | non-narcotic analgesic; T-type calcium channel blocker |
| xl765 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
| azd4547 | [no description available] | low | 0 | 0 | benzamides; N-arylpiperazine; pyrazoles | fibroblast growth factor receptor antagonist |
| N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| entecavir | [no description available] | low | 0 | 0 | benzamides; N-acylpiperidine | |
| acp-196 | [no description available] | low | 0 | 0 | aromatic amine; benzamides; imidazopyrazine; pyridines; pyrrolidinecarboxamide; secondary carboxamide; tertiary carboxamide; ynone | antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
| pf-06463922 | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; azamacrocycle; benzamides; cyclic ether; monofluorobenzenes; nitrile; organic heterotetracyclic compound; pyrazoles | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| DDR1-IN-1 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; benzamides; N-alkylpiperazine; oxindoles; secondary carboxamide | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
| N-[2-methyl-5-[oxo-[3-(1-oxoprop-2-enylamino)-5-(trifluoromethyl)anilino]methyl]phenyl]-5-isoxazolecarboxamide | [no description available] | low | 0 | 0 | benzamides | |
| PF-06446846 | [no description available] | low | 0 | 0 | benzamides; monochloropyridine; piperidines; tertiary carboxamide; triazolopyridine | antilipemic drug; EC 3.4.21.61 (kexin) inhibitor |
| 5,10-methylenetetrahydrofolic acid | [no description available] | low | 0 | 0 | benzamides; methylenetetrahydrofolic acid | |
| N-cyclohexyl-3-methyl-N-[(4-oxo-1H-quinazolin-2-yl)methyl]benzamide | [no description available] | low | 0 | 0 | benzamides |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| Inflammation | 0 | low | 1 | 0 |
| Innate Inflammatory Response | 0 | low | 1 | 0 |